002826 易明医药
已收盘 11-22 15:00:00
资讯
新帖
简况
11月8日易明医药涨停分析:中药,医药,西藏概念热股
证券之星 · 11-08
11月8日易明医药涨停分析:中药,医药,西藏概念热股
异动快报:易明医药(002826)11月8日9点55分触及涨停板
证券之星 · 11-08
异动快报:易明医药(002826)11月8日9点55分触及涨停板
易明医药公布三季报 前三季净利增加75.06%
新浪财经-鹰眼工作室 · 10-30
易明医药公布三季报 前三季净利增加75.06%
易明医药(002826.SZ)发布前三季度业绩,净利润4181.94万元,同比增长75.06%
智通财经 · 10-29
易明医药(002826.SZ)发布前三季度业绩,净利润4181.94万元,同比增长75.06%
易明医药(002826)10月28日主力资金净买入818.13万元
证券之星 · 10-28
易明医药(002826)10月28日主力资金净买入818.13万元
易明医药(002826)9月20日主力资金净买入41.86万元
证券之星 · 09-20
易明医药(002826)9月20日主力资金净买入41.86万元
易明医药(002826)9月18日主力资金净买入117.43万元
证券之星 · 09-18
易明医药(002826)9月18日主力资金净买入117.43万元
易明医药:公司暂无藏药材种植业务
证券之星 · 09-12
易明医药:公司暂无藏药材种植业务
易明医药(002826)9月10日股东户数1.87万户,较上期减少3.43%
证券之星 · 09-12
易明医药(002826)9月10日股东户数1.87万户,较上期减少3.43%
易明医药最新公告:子公司TAPI拟649.12万美元减资开曼彼爱
证券之星 · 09-11
易明医药最新公告:子公司TAPI拟649.12万美元减资开曼彼爱
易明医药(002826.SZ)拟对参股公司开曼彼爱定向减资 涉及649.12万美元
智通财经 · 09-11
易明医药(002826.SZ)拟对参股公司开曼彼爱定向减资 涉及649.12万美元
易明医药(002826)2024年中报简析:净利润增181.56%,三费占比上升明显
证券之星 · 08-17
易明医药(002826)2024年中报简析:净利润增181.56%,三费占比上升明显
图解易明医药中报:第二季度单季净利润同比增105.47%
证券之星 · 08-16
图解易明医药中报:第二季度单季净利润同比增105.47%
易明医药最新公告:上半年净利润3964.6万元 同比增长181.56%
证券之星 · 08-15
易明医药最新公告:上半年净利润3964.6万元 同比增长181.56%
易明医药(002826.SZ)发布上半年业绩,净利润3964.62万元,增长181.56%
智通财经 · 08-15
易明医药(002826.SZ)发布上半年业绩,净利润3964.62万元,增长181.56%
易明医药发布业绩预告,预计上半年净利润3153万元—4532万元,同比增长123.92%—221.86%。本期净利润较上年同期上升,主要系公司于2024年3月29日收到西藏拉萨经济技术开发区管委会拨付的2023年度产业扶持专项资金2818.
华尔街见闻 · 07-12
易明医药发布业绩预告,预计上半年净利润3153万元—4532万元,同比增长123.92%—221.86%。本期净利润较上年同期上升,主要系公司于2024年3月29日收到西藏拉萨经济技术开发区管委会拨付的2023年度产业扶持专项资金2818.
易明医药(002826.SZ)发预增 半年度净利润3153万–4532万元 增长123.92%-221.86%
智通财经 · 07-12
易明医药(002826.SZ)发预增 半年度净利润3153万–4532万元 增长123.92%-221.86%
【易明医药(002826.SZ)发预增 半年度净利润3153万–4532万元 增长123.92%-221.86%】智通财经APP讯,易明医药(002826.
智通财经 · 07-12
【易明医药(002826.SZ)发预增 半年度净利润3153万–4532万元 增长123.92%-221.86%】智通财经APP讯,易明医药(002826.
易明医药(002826.SZ)已耗资5000.06万元回购3.78%股份
智通财经网 · 07-02
易明医药(002826.SZ)已耗资5000.06万元回购3.78%股份
【易明医药(002826.SZ)已耗资5000.06万元回购3.78%股份】智通财经APP讯,易明医药(002826.SZ)发布公告,截至2024年6月30日,公司通过股份回购专用证券账户以集中竞价交易方式累计回购公司股份720.
智通财经 · 07-02
【易明医药(002826.SZ)已耗资5000.06万元回购3.78%股份】智通财经APP讯,易明医药(002826.SZ)发布公告,截至2024年6月30日,公司通过股份回购专用证券账户以集中竞价交易方式累计回购公司股份720.
暂无数据
公司概况
公司名称:
西藏易明西雅医药科技股份有限公司
所属行业:
医药制造业
上市日期:
2016-12-09
主营业务:
西藏易明西雅医药科技股份有限公司主要从事化学药(原料药和制剂)以及中成药的研发、生产和销售。公司主要产品为米格列醇片、醋氯芬酸肠溶片、红金消结片、蒙脱石散、多潘立酮片、阿奇霉素胶囊、氯雷他定片、第三方合作药品。公司重点经营的产品均在品质、资质上具有突出特点,全部列入《国家基本医疗保险、工伤保险和生育保险药品目录》(2022年版),部分产品列入国家基本药物目录,具备全国独家、首家仿制等优势,在细分市场上均具有较强的竞争力和较好的成长空间。
发行价格:
6.06
{"stockData":{"symbol":"002826","market":"SZ","secType":"STK","nameCN":"易明医药","latestPrice":11.05,"timestamp":1732258992000,"preClose":11.26,"halted":0,"volume":5858500,"delay":0,"floatShares":176000000,"shares":191000000,"eps":0.1748,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.21,"latestTime":"11-22 15:00:00","open":11.17,"high":11.47,"low":10.95,"amount":65083000,"amplitude":0.0462,"askPrice":11.06,"askSize":62,"bidPrice":11.05,"bidSize":28,"shortable":0,"etf":0,"ttmEps":0.1748,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":11.26,"symbolType":"stock","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":12.39,"lowLimit":10.13,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":190677750,"pbRate":2.93,"roa":"--","roe":"5.68%","epsLYR":0.08,"committee":0.637481,"marketValue":2107000000,"floatMarketCap":1945000000,"peRate":63.215105,"changeRate":-0.0187,"turnoverRate":0.0333,"status":1},"requestUrl":"/m/hq/s/002826/tweets","defaultTab":"tweets","newsList":[{"id":"2481148154","title":"11月8日易明医药涨停分析:中药,医药,西藏概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481148154","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481148154?lang=zh_cn&edition=full","pubTime":"2024-11-08 15:22","pubTimestamp":1731050526,"startTime":"0","endTime":"0","summary":"证券之星消息,易明医药11月8日涨停收盘,收盘价11.35元。该股于9点55分涨停,未打开涨停,截止收盘封单资金为6167.1万元,占其流通市值3.09%。11月8日的资金流向数据方面,主力资金净流入3718.25万元,占总成交额27.57%,游资资金净流出1579.58万元,占总成交额11.71%,散户资金净流出2138.67万元,占总成交额15.86%。近5日资金流向一览见下表:该股为中药,医药,西藏概念热股。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110800019765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1161","BK1515","002826","BK0033","09939","BK0239","BK0056","BK1574"],"gpt_icon":0},{"id":"2481164158","title":"异动快报:易明医药(002826)11月8日9点55分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2481164158","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481164158?lang=zh_cn&edition=full","pubTime":"2024-11-08 10:01","pubTimestamp":1731031270,"startTime":"0","endTime":"0","summary":"证券之星11月8日盘中消息,9点55分易明医药(002826)触及涨停板。目前价格11.35,上涨9.98%。其所属行业化学制药目前上涨。领涨股为海南海药。该股为中药,医药,西藏概念热股,当日中药概念上涨0.82%,医药概念上涨0.7%,西藏概念上涨0.11%。11月7日的资金流向数据方面,主力资金净流入1021.51万元,占总成交额10.18%,游资资金净流出527.01万元,占总成交额5.25%,散户资金净流出494.5万元,占总成交额4.93%。近5日资金流向一览见下表:易明医药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110800010467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","002826","BK0056","BK0239"],"gpt_icon":0},{"id":"2479231203","title":"易明医药公布三季报 前三季净利增加75.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479231203","media":"新浪财经-鹰眼工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479231203?lang=zh_cn&edition=full","pubTime":"2024-10-30 01:10","pubTimestamp":1730221800,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 10月30日消息,易明医药发布三季度报告。 公告显示,公司前三季度营业收入512,843,177.87元,同比减少4.73%,归属上市公司股东的净利润41,819,396.00元,同比增加75.06%。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:小浪快报","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-10-30/doc-incufzcn1642532.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-10-30/doc-incufzcn1642532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002826","BK0033","BK0239","BK0056"],"gpt_icon":0},{"id":"2479402309","title":"易明医药(002826.SZ)发布前三季度业绩,净利润4181.94万元,同比增长75.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479402309","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479402309?lang=zh_cn&edition=full","pubTime":"2024-10-29 20:51","pubTimestamp":1730206319,"startTime":"0","endTime":"0","summary":"智通财经APP讯,易明医药(002826.SZ)发布2024年三季度报告,前三季度,公司实现营业收入5.13亿元,同比下降4.73%。归属于上市公司股东的净利润4181.94万元,同比增长75.06%。归属于上市公司股东的扣除非经常性损益的净利润1633.85万元,同比增长49.61%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1202860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002826"],"gpt_icon":0},{"id":"2478124103","title":"易明医药(002826)10月28日主力资金净买入818.13万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478124103","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478124103?lang=zh_cn&edition=full","pubTime":"2024-10-28 15:21","pubTimestamp":1730100100,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月28日收盘,易明医药报收于10.28元,上涨7.64%,换手率7.55%,成交量13.29万手,成交额1.34亿元。易明医药主营业务:自主生产药品业务,第三方合作药品业务,原料药业务,药品原材料销售业务,药品推广服务业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102800013577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","002826","BK0056"],"gpt_icon":0},{"id":"2468694658","title":"易明医药(002826)9月20日主力资金净买入41.86万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468694658","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468694658?lang=zh_cn&edition=full","pubTime":"2024-09-20 15:23","pubTimestamp":1726817016,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年9月20日收盘,易明医药报收于7.66元,下跌2.42%,换手率1.6%,成交量2.82万手,成交额2178.47万元。易明医药主营业务:自主生产药品业务,第三方合作药品业务,原料药业务,药品原材料销售业务,药品推广服务业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092000016919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK0033","BK0056"],"gpt_icon":0},{"id":"2468376310","title":"易明医药(002826)9月18日主力资金净买入117.43万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468376310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468376310?lang=zh_cn&edition=full","pubTime":"2024-09-18 15:27","pubTimestamp":1726644472,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年9月18日收盘,易明医药报收于7.57元,下跌3.07%,换手率1.81%,成交量3.18万手,成交额2426.3万元。易明医药主营业务:自主生产药品业务,第三方合作药品业务,原料药业务,药品原材料销售业务,药品推广服务业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091800016683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002826","BK0033","BK0056"],"gpt_icon":0},{"id":"2466122570","title":"易明医药:公司暂无藏药材种植业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2466122570","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466122570?lang=zh_cn&edition=full","pubTime":"2024-09-12 17:02","pubTimestamp":1726131766,"startTime":"0","endTime":"0","summary":"证券之星消息,易明医药(002826)09月12日在投资者关系平台上答复投资者关心的问题。投资者:尊敬的董秘: 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2024年9月10日股东人数是多少?谢谢易明医药董秘:尊敬的投资者,您好。根据中登结算深圳分公司最新下发的股东名册,截至2024年9月10日,本公司股东人数为18,748人。感谢关注。投资者:请问公司开发的藏药材种植业务,在中药材涨价的行情下有没有明显的业绩增长易明医药董秘:尊敬的投资者,您好。公司暂无藏药材种植业务,感谢关注。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091200027161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002826","BK0056","BK0033"],"gpt_icon":0},{"id":"2466827225","title":"易明医药(002826)9月10日股东户数1.87万户,较上期减少3.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2466827225","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466827225?lang=zh_cn&edition=full","pubTime":"2024-09-12 17:01","pubTimestamp":1726131717,"startTime":"0","endTime":"0","summary":"证券之星消息,近日易明医药披露,截至2024年9月10日公司股东户数为1.87万户,较8月9日减少665.0户,减幅为3.43%。在化学制药行业个股中,易明医药股东户数低于行业平均水平,截至9月10日,化学制药行业平均股东户数为3.19万户。从股价来看,2024年8月9日至2024年9月10日,易明医药区间跌幅为4.26%,在此期间股东户数减少665.0户,减幅为3.43%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091200027021.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002826","BK0056","BK0033"],"gpt_icon":0},{"id":"2466128396","title":"易明医药最新公告:子公司TAPI拟649.12万美元减资开曼彼爱","url":"https://stock-news.laohu8.com/highlight/detail?id=2466128396","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466128396?lang=zh_cn&edition=full","pubTime":"2024-09-11 20:11","pubTimestamp":1726056662,"startTime":"0","endTime":"0","summary":"易明医药公告,公司全资子公司TAPI Healthcare Inc.拟定向减资参股公司Pier88Health Limited(简称“开曼彼爱”),总回购价款为649.12万美元。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091100036525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","002826","BK0056","BK0239"],"gpt_icon":0},{"id":"2466836792","title":"易明医药(002826.SZ)拟对参股公司开曼彼爱定向减资 涉及649.12万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2466836792","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466836792?lang=zh_cn&edition=full","pubTime":"2024-09-11 20:10","pubTimestamp":1726056614,"startTime":"0","endTime":"0","summary":"智通财经APP讯,易明医药(002826.SZ)发布公告,公司于2024年9月10日召开第三届独立董事第一次专门会议、第三届董事会战略委员会第六次会议、第三届董事会第十八次临时会议和第三届监事会第十七次临时会议,全票审议通过了《关于对参股公司减资暨关联交易的议案》。公司二级全资子公司TAPI Healthcare Inc.(简称“TAPI”)拟对参股公司Pier 88 Health Limited(简称“开曼彼爱”)进行定向减资。双方拟签署《股份回购协议》,协议约定,TAPI拟出售持有的全部股份,总回购价格为649.12万美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1182154.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0033","BK0239","002826","BK0056"],"gpt_icon":0},{"id":"2460220295","title":"易明医药(002826)2024年中报简析:净利润增181.56%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2460220295","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460220295?lang=zh_cn&edition=full","pubTime":"2024-08-17 06:08","pubTimestamp":1723846103,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期易明医药发布2024年中报。截至本报告期末,公司营业总收入3.52亿元,同比下降6.5%,归母净利润3964.62万元,同比上升181.56%。按单季度数据看,第二季度营业总收入1.92亿元,同比下降6.56%,第二季度归母净利润1174.71万元,同比上升105.47%。本报告期易明医药三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达48.17%。财务费用变动幅度为-41.45%,原因:报告期内短期借款较上年同期减少3,900.00万元,利息支出减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081700011317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826"],"gpt_icon":0},{"id":"2459403040","title":"图解易明医药中报:第二季度单季净利润同比增105.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459403040","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459403040?lang=zh_cn&edition=full","pubTime":"2024-08-16 01:31","pubTimestamp":1723743076,"startTime":"0","endTime":"0","summary":"证券之星消息,易明医药2024年中报显示,公司主营收入3.52亿元,同比下降6.5%;归母净利润3964.62万元,同比上升181.56%;扣非净利润1236.68万元,同比下降1.77%;其中2024年第二季度,公司单季度主营收入1.92亿元,同比下降6.56%;单季度归母净利润1174.71万元,同比上升105.47%;单季度扣非净利润1058.69万元,同比上升122.96%;负债率20.31%,投资收益83.27万元,财务费用-80.75万元,毛利率66.28%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081600001933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826"],"gpt_icon":0},{"id":"2459210784","title":"易明医药最新公告:上半年净利润3964.6万元 同比增长181.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459210784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459210784?lang=zh_cn&edition=full","pubTime":"2024-08-15 20:50","pubTimestamp":1723726213,"startTime":"0","endTime":"0","summary":"易明医药公布半年度报告,营业收入3.5亿元,同比下降6.50%,净利润3964.6万元,同比增长181.56%。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081500043236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826"],"gpt_icon":0},{"id":"2459447834","title":"易明医药(002826.SZ)发布上半年业绩,净利润3964.62万元,增长181.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459447834","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459447834?lang=zh_cn&edition=full","pubTime":"2024-08-15 18:54","pubTimestamp":1723719261,"startTime":"0","endTime":"0","summary":"智通财经APP讯,易明医药(002826.SZ)发布2024年半年度报告,报告期内,公司实现营业收入3.52亿元,同比下降6.50%。实现归属于上市公司股东的净利润3964.62万元,同比增长181.56%。实现归属于上市公司股东的扣除非经常性损益的净利润1236.68万元,同比下降1.77%。基本每股收益0.21元。报告期内,经营活动产生的现金流量净额较上年同期减少40.90%,主要系上年同期收回期初第三方合作品种应收账款及本报告期未收回第三方合作品种应收账款所致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1164830.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002826"],"gpt_icon":0},{"id":"2450308800","title":"易明医药发布业绩预告,预计上半年净利润3153万元—4532万元,同比增长123.92%—221.86%。本期净利润较上年同期上升,主要系公司于2024年3月29日收到西藏拉萨经济技术开发区管委会拨付的2023年度产业扶持专项资金2818.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450308800","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450308800?lang=zh_cn&edition=full","pubTime":"2024-07-12 16:22","pubTimestamp":1720772565,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK0033","BK0056","BK0239","002826"],"gpt_icon":0},{"id":"2450308841","title":"易明医药(002826.SZ)发预增 半年度净利润3153万–4532万元 增长123.92%-221.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450308841","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450308841?lang=zh_cn&edition=full","pubTime":"2024-07-12 16:15","pubTimestamp":1720772136,"startTime":"0","endTime":"0","summary":"智通财经APP讯,易明医药(002826.SZ)披露2024年半年度业绩预告,该公司预计报告期归属于上市公司股东的净利润3153万元–4532万元,同比增长123.92%-221.86%。扣除非经常性损益后的净利润971万元–1395万元,同比变动-22.88%-10.80%。据悉,本期净利润较上年同期上升,主要系公司于2024年3月29日收到西藏拉萨经济技术开发区管理委员会拨付的2023年度产业扶持专项资金2818.50万元,公司于实际收到款项的当月计入2024年其他收益,该补助增加公司2024年度利润总额2818.50万元,且公司根据谨慎性原则,将该部分政府补助记入非经常性损益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1149956.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002826"],"gpt_icon":0},{"id":"2450308812","title":"【易明医药(002826.SZ)发预增 半年度净利润3153万–4532万元 增长123.92%-221.86%】智通财经APP讯,易明医药(002826.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450308812","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450308812?lang=zh_cn&edition=full","pubTime":"2024-07-12 16:15","pubTimestamp":1720772136,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0056","BK0239","002826","BK0033"],"gpt_icon":0},{"id":"2448818742","title":"易明医药(002826.SZ)已耗资5000.06万元回购3.78%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2448818742","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448818742?lang=zh_cn&edition=full","pubTime":"2024-07-02 16:50","pubTimestamp":1719910234,"startTime":"0","endTime":"0","summary":"智通财经APP讯,易明医药(002826.SZ)发布公告,截至2024年6月30日,公司通过股份回购专用证券账户以集中竞价交易方式累计回购公司股份720.38万股,占公司目前总股本3.78%,其中,最高成交价为8.96元/股,最低成交价为5.84元/股,回购总金额为5000.06万元(不含交易费用)。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1144320.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0033","BK0239","BK0056","002826"],"gpt_icon":0},{"id":"2448418742","title":"【易明医药(002826.SZ)已耗资5000.06万元回购3.78%股份】智通财经APP讯,易明医药(002826.SZ)发布公告,截至2024年6月30日,公司通过股份回购专用证券账户以集中竞价交易方式累计回购公司股份720.","url":"https://stock-news.laohu8.com/highlight/detail?id=2448418742","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448418742?lang=zh_cn&edition=full","pubTime":"2024-07-02 16:50","pubTimestamp":1719910234,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["161027","BK0033","BK0056","002826","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2016-12-09","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区林琼岗路6号","stockEarnings":[{"period":"1week","weight":0.0203},{"period":"1month","weight":0.1869},{"period":"3month","weight":0.4351},{"period":"6month","weight":0.236},{"period":"1year","weight":-0.1214},{"period":"ytd","weight":-0.0659}],"companyName":"西藏易明西雅医药科技股份有限公司","boardCode":"AI0027","perCapita":"10022股","boardName":"医药制造业","registeredCapital":"19067万元","compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0108},{"period":"3month","weight":0.1446},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.0671},{"period":"ytd","weight":0.0982}],"survey":" 西藏易明西雅医药科技股份有限公司主要从事化学药(原料药和制剂)以及中成药的研发、生产和销售。公司主要产品为米格列醇片、醋氯芬酸肠溶片、红金消结片、蒙脱石散、多潘立酮片、阿奇霉素胶囊、氯雷他定片、第三方合作药品。公司重点经营的产品均在品质、资质上具有突出特点,全部列入《国家基本医疗保险、工伤保险和生育保险药品目录》(2022年版),部分产品列入国家基本药物目录,具备全国独家、首家仿制等优势,在细分市场上均具有较强的竞争力和较好的成长空间。","serverTime":1732320655688,"listedPrice":6.06,"stockholders":"17567人(较上一季度减少2.07%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"易明医药,002826,易明医药股票,易明医药股票老虎,易明医药股票老虎国际,易明医药行情,易明医药股票行情,易明医药股价,易明医药股市,易明医药股票价格,易明医药股票交易,易明医药股票购买,易明医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}